Biotechpharma UAB, a biopharmaceutical CDMO, has invested more than €50 million to further expand its fermentation capacity to 5,000 L, along with a new process development lab.   Dr. Vladas Bumelis, chairman of the board, said, “The expansion comes amid growing global demand for flexible and responsive outsourcing partners that are able to support the full product lifecycle, from upstream and downstream process development and optimization to GMP manufacturing of drug substance and formulated...